Synthesis of 5,11-Methenyltetrahydrohomofolate and Its Antifolate Activity in Vitro

Carol A. Caperelli, Paul Domanico, Stephen J. Benkovic

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

The synthesis of 5,11-methenyltetrahydrohomofolate was accomplished by treatment of tetrahydrohomofolate (H4homofolate) with triethyl orthoformate in glacial acetic acid. This compound is a homofolate analogue of 5,10-methenyltetrahydrofolate which serves as one precursor to the 10-formyl one-carbon donor for the first transformylation in de novo purine biosynthesis, namely, the conversion of glycinamide ribonucleotide (GAR) to N-formylglycinamide ribonucleotide (FGAR), catalyzed by the enzyme glycinamide ribonucleotide transformylase (EC 2.1.2.2). The analogue proved to retard the rate of formation of formylglycinamide ribonucleotide apparently by inhibiting the rate of synthesis of 10-formyltetrahydrofolate, the actual cofactor for the transformylase enzyme, from 5,10-methenyltetrahydrofolate. Its inhibition of the enzyme, 5,10-methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9), was competitive against (+)-L-5,10-methenyltetrahydrofolate, with a Ki = 41 µM. This derivative of homofolate may be responsible for its inhibition of purine biosynthesis in Sarcoma 180 cells.

Original languageEnglish (US)
Pages (from-to)1086-1088
Number of pages3
JournalJournal of Medicinal Chemistry
Volume24
Issue number9
DOIs
StatePublished - Sep 1981

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Synthesis of 5,11-Methenyltetrahydrohomofolate and Its Antifolate Activity in Vitro'. Together they form a unique fingerprint.

Cite this